Works matching DE "AMBRY Genetics Corp."

Myriad sues developers of competing breast cancer tests.

Published in:

Nature Medicine, 2013, v. 19, n. 8, p. 948, doi. 10.1038/nm0813-948

By:

• Scudellari, Megan

Publication type:

Article